Andrew Geyer - Concepedia

Author

Andrew Geyer

Pfizer (United States)ORCID

Also Known As

Andrew G. Geyer, Andrew Geyer

Publications

293

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Abbott Fund

About

Andrew Geyer is an author at Pfizer (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	129
2	Chemistry	2	2	65
3	Engineering	1	1	41
4	Biochemistry	1	1	28
5	Macromolecular Science	1	1	41

Andrew Geyer

Publications

288

Citations

H-Index

Page 1

	Year	Citations
Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of <i>N</i>-Phenyl Amide 6-Substitution Michael Wendt, Todd W. Rockway, Andrew Geyer, Journal of Medicinal Chemistry	2003	66
Discovery of a Series of Imidazo[4,5-<i>b</i>]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ Agustin Casimiro‐Garcia, Gary F. Filzen, Declan Flynn, Journal of Medicinal Chemistry	2011	52
P2Y1 receptor antagonists as novel antithrombotic agents Jeffrey A. Pfefferkorn, Chulho Choi, Thomas Winters, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyPlatelet Aggregation InhibitorsThrombosisBlood PlateletMedicine	2008	51
Rasta Silanes: New Silyl Resins with Novel Macromolecular Architecture via Living Free Radical Polymerization Craig W. Lindsley, John C. Hodges, Gary F. Filzen, Journal of Combinatorial Chemistry New Silyl ResinsMacromolecular ChemistryEngineeringRasta SilanesOrganic Chemistry	2000	41
Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors Michael Wendt, Andrew Geyer, William J. McClellan, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineRational Drug DesignMechanism Of Action	2004	28
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties Milan Bruncko, William J. McClellan, Michael Wendt, Bioorganic & Medicinal Chemistry Letters Improved Pharmacokinetic PropertiesMedicinePharmacological AgentPharmacotherapyDrug Development	2004	26
Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor δ agonists Gary F. Filzen, Larry Bratton, Xue‐Min Cheng, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologySelective BenzothiopheneMedicineMechanism Of ActionPharmacological Agent	2007	24

Page 1